ImpriMed has appointed Valerie Goodwin-Adams as Chief Commercial Officer to lead its commercial expansion. This follows the company's achievement of processing its 10,000th canine cancer sample and moving to a new advanced laboratory in Palo Alto.
Company Information
Company
ImpriMed
Location
Mountain View, California, United States
About
ImpriMed provides cutting-edge personalized medicine easily accessible for pets with blood cancer diseases. ImpriMed’s key product, Personalized Prediction Profile, has been used by board-certified veterinary oncologists, helping over 4,000 dogs with lymphoma and leukemia. With ImpriMed’s services, veterinarians make their treatment decisions quickly and with confidence. This innovative approach to cancer care has been published in a scientific journal and presented at major conferences and is supported by over 200 veterinary oncologists at 80+ specialty hospitals in the US.
Fundz sees it the moment ImpriMed changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Mountain ViewBiotechnologyHealth CareArtificial IntelligenceMedicalHealth Diagnostics